You are here

Home » Content

Böbrek Transplantasyonu Sonrası Erken Dönemde Siklosporin İlişkili Trombotik Mikroanjiyopati Gelişen Olgunun Takrolimus ve Plazma Değişimi ile Tedavisi

A Case with Cyclosporine-Associated Thrombotic Microangiopathy in Early Stage after Kidney Transplantation Salvage with Tacrolimus and Plasma Exchange

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2010
DOI: 
10.5262/tndt.2010.1001.11

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Thrombotic microangiopathy (TMA)/uremic hemolytic syndrome is a rarely seen complication after kidney transplantation and might be associated with cyclosporine-A. It can be confused with acute rejection when no systemic symptoms are present. We review a successfully treated case in which cyclosporine associated TMA developed after a second kidney transplantation in this article.
Bookmark/Search this post with
Abstract (Original Language): 
Trombotik mikroanjiopati (TMA)/hemolitik üremik sendrom böbrek transplantasyonu sonrası nadir görülen bir komplikasyon olup siklosporin-A ile ilişkili olabilir. Sistemik bulgular olmadığında akut rejeksiyon ile karışabilir. Yazımızda ikinci kez böbrek transplantasyonu yapıldıktan sonra siklosporin ilişkili TMA gelişen ve başarılı şekilde tedavi edilen bir olgu sunulacaktır
FULL TEXT (PDF): 
PDF icon arastrmx_172977_19_pp_62-64.pdf
  • 1
62-64
  • Turkish

REFERENCES

References: 

1. Zarifian A, Meleg-Smith S, O’donovan R, Tesi RJ, Batuman V:
Cyclosporine-associated thrombotic microangiopathy in renal
allografts. Kidney Int 1999;55:2457-2466
2. Reynolds JC, Agodoa LY, Yuan CM, Abbott KC: Thrombotic
microangiopathy after renal transplantation in the United States.
Am J Kidney Dis 2003;42:1058-1068
3. Pham PT, Danovitch GM, Wilkinson AH, Gritsch HA, Pham PC, Eric
TM, Kendrick E, Charles LR, Tsai HM: Inhibitors of ADAMTS13:
a potential factor in the cause of thrombotic microangiopathy in a
renal allograft recipient. Transplantation 2002;74:1077-1080
Aybal A ve ark: Böbrek Transplantasyonu Sonrası Erken Dönemde Siklosporin İlişkili
Trombotik Mikroanjiopati Gelişen Olgunun Takrolimus ve Plazma Değişimi ile Tedavisi
Cilt/Vol: 19, No: 1, 2010, Sayfa/Page: 62-64
63
Türk Nefroloji Diyaliz ve Transplantasyon Dergisi
Turkish Nephrology, Dialysis and Transplantation Journal
4. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi
G: Cyclosporin-induced endothelial cell injury. Lab Invest
1986;55:455-462
5. Remuzzi G, Bertani T: Renal vascular and thrombotic effects of
cyclosporine. Am J Kidney Dis 1989;13:261-272
6. Schwimmer J, Nadasdy TA, Spitalnik PF, Kaplan KL, Zand MS:
De novo thrombotic microangiopathy in renal transplant recipients:
A comparison of hemolytic uremic syndrome with localized renal
thrombotic microangiopathy. Am J Kidney Dis 2003;41:471-479
7. Franz M, Regele H, Schmaldienst S, Stummvoll HK, Hörl WH,
Pohanka E: Posttransplant hemolytic uremic syndrome in adult
retransplanted kidney graft recipients: advantage of FK506 therapy?
Transplantation 1998; 15;66(9):1258-1262
8. Mor E, Lustig S, Tovar A, Bar-Nathan N, Shharabani E, Shapira
Z, Yusim A: Thrombotic microangiopathy early after kidney
transplantation: Hemolytic uremic syndrome or vascular rejection?
Transplant Proc 2000; 32(4):686-687
9. Ponticelli C, Banfi G: Thrombotic microangiopathy after kidney
transplantation. Transpl Int 2006;19:789-794

Thank you for copying data from http://www.arastirmax.com